ABSCIENCES (EPA:AB) | Finanzwire

BRIEF

published on 07/30/2025 at 07:50, 9 months 2 days ago

AB Science Advances in AML Study With New European Approvals

Regulatory Approval Market Potential AB8939 Venetoclax AML Study
PRESS RELEASE

published on 07/30/2025 at 07:45, 9 months 2 days ago

AB Science receives regulatory approval from European countries to initiate third stage of Phase I/II study combining its molecule AB8939 with venetoclax for the treatment of AML
AB Science receives regulatory approval from European countries to initiate third stage of Phase I/II study combining AB8939 with venetoclax for treatment of acute myeloid leukemia

Regulatory Approval AB Science AB8939 Venetoclax Phase I/II Study
BRIEF

published on 07/24/2025 at 08:01, 9 months 8 days ago

AB Science Gains Approval for Phase 3 ALS Masitinib Study Across Europe

Phase 3 Trial ALS AB Science Masitinib European Approval
PRESS RELEASE

published on 07/24/2025 at 07:56, 9 months 8 days ago

AB Science has received approval from several European countries to initiate the confirmatory phase 3 study of masitinib in ALS
AB Science receives approval from European countries to initiate Phase 3 study of masitinib in ALS following protocol validation by EMA and FDA

Phase 3 Study ALS AB Science Masitinib EMA
BRIEF

published on 07/08/2025 at 08:06, 9 months 24 days ago

AB Science Completes EUR 1.925 Million Private Placement

Private Placement Share Issuance Biotech Funding AB Science AB8939 Program
PRESS RELEASE

published on 07/08/2025 at 08:01, 9 months 24 days ago

AB Science announces the successful completion of a EUR 1.925 million private placement
AB Science successfully completes EUR 1.925 million private placement to finance ongoing activities and focus on AB8939 program development. New shares to be admitted to trading on Euronext Paris

Private Placement Euronext Paris AB Science AB8939 Program EUR 1.925 Million
BRIEF

published on 07/04/2025 at 08:06, 9 months 28 days ago

AB Science: Green light for phase 3 study of masitinib in prostate cancer

Phase 3 AB Science Masitinib Prostate Cancer FDA And EMA
BRIEF

published on 07/01/2025 at 10:13, 10 months ago

Results of the AB Science General Meeting

Share Capital Voting Rights Resolutions General Assembly AB Science
BRIEF

published on 06/30/2025 at 08:08, 10 months 1 day ago

AB Science Secures Two-Year Loan Repayment Deferment

Financial Strategy Debt Restructuring AB Science Loan Deferment Creditors Agreement
PRESS RELEASE

published on 06/30/2025 at 08:03, 10 months 1 day ago

AB Science provides an update on the renegotiation of loan repayment terms with its financial creditors
AB Science reaches agreement with financial creditors to defer loan repayment terms by 24 months, leading to investment in R&D. Negotiations ongoing for postponement of EIB COVID loan repayment

Financial Creditors R&D Investment Loan Repayment AB Science EIB COVID Loan

Published on 05/02/2026 at 00:00, 39 minutes ago

Redwood AI Announces Enhanced AI Models, Increasing Evaluated Chemical Reactions Following Preliminary Results from UBC Collaboration
Published on 05/02/2026 at 00:00, 39 minutes ago

Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies
Published on 05/01/2026 at 22:30, 2 hours 9 minutes ago

Nextech3D.ai Appoints New Independent Auditor
Published on 05/01/2026 at 22:30, 2 hours 9 minutes ago

Integrated Rewards Achieves SOC 2 Compliance to Support Enterprise-Scale Growth Across Canada's Card-Linked Rewards Network as EQ Closes Convertible Debt Financing
Published on 05/01/2026 at 22:30, 2 hours 9 minutes ago

Apex Critical Metals Announces Extension of Marketing Agreement with Rumble Strip Media Inc.

View all ACCESSWIRE

Published on 05/01/2026 at 19:23, 5 hours 16 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/01/2026 at 18:40, 5 hours 59 minutes ago

Holding(s) in Company
Published on 05/01/2026 at 17:47, 6 hours 52 minutes ago

Key Figures 30.04.2026
Published on 05/01/2026 at 17:45, 6 hours 54 minutes ago

Burkhalter Group acquires Progressio Holding GmbH and anplaq ag, Tamins (GR)
Published on 05/01/2026 at 17:21, 7 hours 18 minutes ago

Fuller, Smith & Turner PLC: Total Voting Rights and Treasury Shares

View all EQS

Published on 04/30/2026 at 20:00, 1 day 4 hours ago

AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 19:16, 1 day 5 hours ago

AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:00, 1 day 5 hours ago

Capital increase through exercise of subscription rights
Published on 04/30/2026 at 18:10, 1 day 6 hours ago

Minutes of the Combined General Meeting held on April 30, 2026
Published on 04/30/2026 at 18:00, 1 day 6 hours ago

TF1 Q1 2026 results - Press release

View all LES ECHOS COMFI WIRE

News